NDAORALTABLET, DELAYED RELEASE
Approved
Dec 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
ARTHROTEC (diclofenac sodium and misoprostol) by Pfizer is sodium/misoprostol is a combination product containing diclofenac sodium, an nsaid with analgesic, anti-inflammatory and antipyretic properties, and misoprostol, a gi mucosal protective prostaglandin-1 (pge1) analog. Approved for prostaglandin e1 analog [epc], the signs, symptoms of osteoarthritis and 6 more indications. First approved in 1997.
Drug data last refreshed Yesterday
Mechanism of Action
sodium/misoprostol is a combination product containing diclofenac sodium, an NSAID with analgesic, anti-inflammatory and antipyretic properties, and misoprostol, a GI mucosal protective prostaglandin-1 (PGE1) analog. Diclofenac The mechanism of action of diclofenac, like that of other NSAIDs, is…
Worked on ARTHROTEC at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.